- XVII Congreso Latinoamericano de Salud Ocupacional - 11 a 15 out. 2021 – San José – Costa Rica - IX Congreso Iberoamericano de Investigación Cualitativa en Salud - 13 a 15 out. 2021 – Montevideo - Uruguai - 6th World Congress on Controversies in Breast Cancer (CoBrCa) - 14 a 16 out. 2021 - Brisbarne - Australia - 3º Congresso Nacional de Fisiologia Clínica - 15 a 17 out. 2021 - Coimbra - Portugal - XXII Congreso Nacional de Oftalmología - 21 a 23 out. 2021- Reserva Conchal – Costa Rica
- 7-10/11 - XIII Congresso Brasileiro de Controle de Infecção e EpidemiologiaHospitalar
TÉTANO (1) HEIJSTEK, M. W. et al. Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study. Annals of the rheumatic diseases, London, v. 71, n. 6, p. 948-954, June 2012. 
(2) HIROBE, S. et al. Clinical study of transcutaneous vaccination using a hydrogel patch for tetanus and diphtheria, Vaccine, Kidlington, v. 30, n. 10, p. 1847-1854, Feb. 2012. (3) HOPE, V. D. et al. A decade of spore-forming bacterial infections among European injecting drug users: pronounced regional variation. American journal of public health, Washington, v. 102, n. 1, p. 122-125, Jan. 2012. (4) LOAN, H. T. et al. Semi-recumbent body position fails to prevent healthcare-associated pneumonia in Vietnamese patients with severe tetanus. Transactions of the Royal Society of Tropical Medicine and Hygiene, London, v. 106, n. 2, p. 90-97, Feb. 2012. (5) MANGILLI, L. D. et al. Rehabilitative management of swallowing and oral-motor movements in patients with tetanus of a public service in Brazil. Acta tropica, Basel, v. 122, n. 3, p. 241-246, June 2012. (6) MORI, M. et al. Postoperative tetanus after laparoscopic obturator hernia repair for strangulated ileus: report of a case. Surgery today, Tokyo, v. 42, n. 5, p. 470-474, May 2012. (7) SELMAN, M. H. et al. Changes in antigen-specific IgG1 Fc N-glycosylation upon influenza and tetanus vaccination. Molecular & cellular proteomics, Bethesda, v. 11, n. 4, p. M111.014563, Apr. 2012. (8) TIERNEY, R. et al. A single-dose cytomegalovirus-based vaccine encoding tetanus toxin fragment C induces sustained levels of protective tetanus toxin antibodies in mice. Vaccine, Kidlington, v. 30, n. 20, p. 3047-3052, Apr. 2012. (9) VAN DER MEEREN, O. et al. Immunogenicity of InfanrixTM hexa administered at 3, 5 and 1 months of age. Vaccine, Kidlington, v. 30, n. 17, p. 2710-2714, Apr. 2012. (10) WESTON, W. M. et al. Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix®): results of two randomized trials. Vaccine, Kidlington, v. 30, n. 9, p. 1721-1728, Feb. 2012. 
DENGUE (1) CARNEIRO, A. R. et al. Molecular characterisation of dengue virus type 1 reveals lineage replacement during circulation in Brazilian territory. Memórias do Instituto Oswaldo Cruz, Rio de Janeiro, v.107, n.6, p. 805-812. Sep. 2012, (2) MACIEL-DE-FREITAS, R. et al. Why do we need alternative tools to control mosquito-borne diseases in Latin America? Memórias do Instituto Oswaldo Cruz, Rio de Janeiro, v.107, n.6, p. 828-829, Sep. 2012. (3) SALJE, H. et al. Revealing the microscale spatial signature of dengue transmission and immunity in an urban population. Proceedings of the national academy of sciences of the United States of America, Washington, v. 109, n. 24, p. 9535-9538, Jun. 2012. (4) BLAGROVE, M. S.; ARIAS-GOETA, C.; FAILLOUX, A. B.; SINKINS, S. P. Wolbachia strain wMel induces cytoplasmic incompatibility and blocks dengue transmission in Aedes albopictus. Proceedings of the national academy of sciences of the United States of America, Washington, v. 109, n. 1, p. 255-260, Jun. 2012. (5) SIM, S.; RAMIREZ, J. L.; DIMOPOULOS, G. Dengue virus infection of the Aedes aegypti salivary gland and chemosensory apparatus induces genes that modulate infection and blood-feeding behavior. PloS pathogens, San Francisco, v. 8, n. 3, e1002631, 2012.
(1) MEIER, B.; FRANK, B.; WAHL, A.; DIENER, H.C. Secondary stroke prevention: patent foramen ovale, aortic plaque, and carotid stenosis. European heart journal, London, v. 33, n. 6, p. 705-713, 713a, 713b, Mar. 2012. (2) ROSE, S. A. semiconductor chips, genes, and stem cells: new wine for new bottles? (3) BADER, M. A.; GASSMANN, O.; ZIEGLER, N.; RUETHER, F. Getting the most out of your IP--patent management along its life cycle. Drug discovery today, Oxford, v. 17, n. 7-8, p. 281-284, Apr. 2012. (4) AQUINO, J. U. et al. Experimental canine model for sentinel lymph node biopsy in the vulva using technetium and patent blue dye. Acta Cirurgica Brasileira , São Paulo, v.27, n.2, p. 102-108. 2012. (5) BUENO, C. S.; MOREIRA, A. C. ; OLIVEIRA, K.R. Cost of drugs used to treat cardiovascular disease in Brazil. Revista Panamericana de Salud Publica, Washington, v. 31, n. 1, p. 62-67, Jan. 2012.
American journal of law and medicine, Boston, v. 38, n.1, p. 113-157, 2012.
Projeto Original
Conceição Carvalho - conceicao.carvalho@icict.fiocruz.br
Diones Ramos - diones.ramos@icict.fiocruz.br
Fátima Duarte - fatima.duarte@icict.fiocruz.br
Mônica Garcia - monica.garcia@icict.fiocruz.br
Rafael Cavadas - rcavadas@icict.fiocruz.br
Michele Nogueira -
Fernando Proença - fernando.proenca@icict.fiocruz.br
Programação Visual
Marcelo Vasconcellos - marcelo.vasconcellos@icict.fiocruz.br
Revisão de Conteúdo
Cristiane d'Avila - cristiane.davila@icict.fiocruz.br
Graça Portela - graca.portela@icict.fiocruz.br
Desenvolvimento de Sistema
Rosicler Magalhães- rosicler.magalhaes@icict.fiocruz.br
